Sabadell Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2.78M Sell
135,053
-2,948
-2% -$64.1K 0.58% 49
2023
Q1
$3.26M Buy
+138,001
New +$3.71M 0.69% 47

Other funds holding OGN

Sabadell Asset Management's OGN Position: Q2 2023 in Review

Sabadell Asset Management reduced its Organon & Co (OGN) stake by 2.1% in Q2 2023, selling an estimated $64.1K and leaving 135,053 shares worth $2.78M. The position accounts for 0.58% of the portfolio, ranked #49.

Sabadell Asset Management first reported a position in OGN in Q1 2023 and has held it in 2 quarters since. The position peaked at $3.26M in Q1 2023. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Sabadell Asset Management held 135,053 shares of Organon & Co worth $2.78M as of Q2 2023.
  • Sabadell Asset Management sold 2,948 Organon & Co shares in Q2 2023, an estimated $64.1K.
  • Organon & Co made up 0.58% of Sabadell Asset Management's portfolio in Q2 2023, its #49 holding.
  • Sabadell Asset Management first reported a position in Organon & Co in Q1 2023 and has held it in 2 quarters since.
  • Sabadell Asset Management's Organon & Co position peaked at $3.26M in Q1 2023.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.